Background: Somatic Symptom Disorder often co-exists with depression, posing a challenge for effective treatment despite numerous interventions attempted. Repetitive Transcranial Magnetic Stimulation (rTMS), an FDA-approved non-invasive cortical stimulation for mild resistant depression, holds promise when targeting the prefrontal cortex (PFC). In this case report, we explore the efficacy of rTMS in addressing Somatic Symptom Disorder. Case Report: A 65-year-old female with multiple medical co-morbidities and polypharmacy presented with persistent somatic complaints spanning two years. Extensive medical evaluations yielded normal results. Various psychiatric consultations led to multiple antidepressant and adjunct antipsychotic prescriptions, yet no improvement was observed. Hospital admission for observation and management ensued. Initially on Fluoxetine, Olanzapine, and Topiramate, the patient exhibited no signs of improvement. Subsequently, rTMS, employing the Intermittent Theta Burst (iTBS) protocol, was incorporated into her treatment plan. Upon completion of the rTMS sessions, the patient achieved a full recovery, reporting no residual complaints. Conclusion: This case report highlights the effectiveness of rTMS in the management of Persistent Somatic Symptom Disorder, underscoring its potential as a therapeutic option for this challenging condition.